Acta Pharmacol Sin. 2023 May;44(5):940-953.doi: 10.1038/s41401-022-01014-1. Epub 2022 Nov 10.(IF:8.2).
2023-05-12Acta Pharmacol Sin. 2023 May;44(5):940-953.doi: 10.1038/s41401-022-01014-1. Epub 2022 Nov 10. (IF:8.2).Inhibiting von Hippel‒Lindau protein-mediated Dishevelled ubiquitination protects against experimental parkinsonism (蛋白介导的去水平泛素化可预防实验性帕金森病)